Physician profile
Marc Janis
NPI 1669587879
$13,373.65
in general payments reported to CMS, 2019-2025
48 companies · $2,621 in 2025
The $2,621 reported for 2025 was more than what 85% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,550 · 2020: $980 · 2021: $1,423 · 2022: $1,818 · 2023: $2,173 · 2024: $2,809 · 2025: $2,621.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,173 · Travel and Lodging: $240 · Education: $190.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,172.96 |
| Travel and Lodging | $239.57 |
| Education | $189.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $2,619.27 | 2019-2025 | Erleada, Akeega, Balversa |
| Sumitomo Pharma America, INC. | $1,716.56 | 2023-2025 | Gemtesa, Orgovyx |
| Astellas Pharma US INC | $1,444.78 | 2019-2025 | Xtandi, Myrbetriq, Veozah |
| Coloplast Corp | $627.63 | 2021-2025 | Titan, Altis |
| Pfizer INC. | $602.75 | 2019-2025 | |
| Myriad Genetic Laboratories, INC. | $559.07 | 2022-2025 | Myrisk, Prolaris |
| Olympus America INC. | $540.08 | 2022-2025 | Itind System |
| Procept Biorobotics Corporation | $510.42 | 2024 | Aquabeam System |
| Tolmar, INC. | $347.19 | 2023-2025 | Jatenzo, Eligard |
| Myovant Sciences INC. | $341.42 | 2021-2022 | |
| Endo Pharmaceuticals INC. | $316.27 | 2019-2024 | Xiaflex, Aveed, Edex |
| Urovant Sciences INC | $291.27 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $288.72 | 2020-2025 | Lynparza, Keytruda |
| Acerus Pharmaceuticals Corporation | $287.68 | 2020-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $281.55 | 2021-2025 |
Show all 48 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aytu Biopharma, INC. | $222.44 | 2019-2020 | |
| Clarus Therapeutics INC. | $211.05 | 2021 | |
| Amgen INC. | $186.73 | 2019-2023 | Xgeva |
| Progenics Pharmaceuticals, INC. | $158.99 | 2023-2025 | Pylarify |
| Endo USA, INC. | $152.09 | 2024-2025 | Xiaflex, Aveed |
| Neotract INC. | $129.34 | 2019-2020 | |
| Allergan, INC. | $125.79 | 2019-2021 | |
| Abbvie INC. | $114.22 | 2022-2025 | |
| Teleflex LLC | $101.69 | 2021-2024 | Urolift, Rusch |
| Comsort, INC | $100.00 | 2019 | |
| Foundation Medicine, INC. | $98.13 | 2021-2022 | |
| Boston Scientific Corporation | $80.59 | 2020-2025 | Ams 700 |
| Tolmar Pharmaceuticals, INC. | $77.27 | 2019-2021 | |
| Ferring Pharmaceuticals INC. | $76.18 | 2019-2025 | Adstiladrin |
| Blue Earth Diagnostics | $74.30 | 2022-2023 | |
| Novo Nordisk INC | $73.50 | 2024 | Rivfloza |
| Alnylam Pharmaceuticals INC. | $72.60 | 2020-2024 | Givlaari |
| Axonics, INC. | $71.69 | 2023-2024 | Bulkamid, Axonics |
| Urogen Pharma, INC. | $66.96 | 2022-2024 | |
| Verity Pharmaceuticals INC. | $58.19 | 2024-2025 | Trelstar |
| Accord Healthcare, INC. | $52.77 | 2023-2024 | |
| Antares Pharma, INC. | $50.16 | 2019-2024 | Xyosted |
| Calyxo, INC. | $28.56 | 2025 | Cvac Aspiration System |
| Civco Medical Instruments | $27.20 | 2025 | |
| Agiliti Surgical, INC. | $25.39 | 2025 | Koelis Trinity Mri/US Fusion, Ge Healthcare Bkfusion Prostate Biopsy, Sonablate Hifu |
| 180 Medical, INC. | $24.37 | 2023 | Gentlecath Glide |
| Acelrx Pharmaceuticals, INC. | $23.52 | 2019-2020 | |
| Dentsply Ih Ab | $23.05 | 2023 | Lofric |
| Halozyme INC | $22.20 | 2023 | |
| Kyowa Kirin, INC. | $20.59 | 2025 | |
| Angiodynamics, INC. | $19.88 | 2025 | Nanoknife |
| Dentsply Ih INC. | $17.44 | 2021 | |
| Cumberland Pharmaceuticals, INC. | $12.11 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marc Janis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.